Macrophage migration and gene expression in response to tumor hypoxia
暂无分享,去创建一个
[1] A. Harris,et al. The macrophage – a novel system to deliver gene therapy to pathological hypoxia , 2000, Gene Therapy.
[2] F. Balkwill,et al. Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation – a potential mechanism , 2001, European journal of immunology.
[3] N. Ferrara,et al. The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.
[4] Adrian L. Harris,et al. Targeting gene expression to hypoxic tumor cells , 1997, Nature Medicine.
[5] Barbara Bottazzi,et al. Autocrine Production of IL-10 Mediates Defective IL-12 Production and NF-κB Activation in Tumor-Associated Macrophages1 , 2000, The Journal of Immunology.
[6] G. Stamp,et al. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. , 1997, The American journal of pathology.
[7] M. Weil,et al. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. , 2002, Cancer research.
[8] F. Balkwill,et al. Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] C. Denkert,et al. Suppression of the reactive oxygen intermediates production of human macrophages by colorectal adenocarcinoma cell lines , 1999, Immunology.
[10] Geoffrey C Gurtner,et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.
[11] S. Libutti,et al. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. , 1994, The Journal of biological chemistry.
[12] A. Harris,et al. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .
[13] J. Peacock,et al. Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors. , 1978, British Journal of Cancer.
[14] Nooruddin Khan,et al. Interleukin‐10 (IL‐10) mediated suppression of IL‐12 production in RAW 264.7 cells also involves c‐rel transcription factor , 2005, Immunology.
[15] D. Laskin,et al. Activation of alveolar macrophages by native and synthetic collagen-like polypeptides. , 1994, American journal of respiratory cell and molecular biology.
[16] R. Strieter,et al. The Regulation of Interleukin-8 by Hypoxia in Human Macrophages—A Potential Role in the Pathogenesis of the Acute Respiratory Distress Syndrome (ARDS) , 2001, Molecular medicine.
[17] Lieve Moons,et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. , 2005, Cancer research.
[18] P. Stattin,et al. Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. , 2000, International journal of oncology.
[19] H. Moch,et al. Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL , 2003, Nature.
[20] D. Mullins,et al. Tumor‐induced immune dysfunction: the macrophage connection , 1998, Journal of leukocyte biology.
[21] A. Lucci,et al. Role of cyclooxygenase-2 in breast cancer. , 2002, The Journal of surgical research.
[22] A. Kraft,et al. Conditional Expression of the Mitogen-activated Protein Kinase (MAPK) Phosphatase MKP-1 Preferentially Inhibits p38 MAPK and Stress-activated Protein Kinase in U937 Cells* , 1997, The Journal of Biological Chemistry.
[23] A. Giaccia,et al. Hypoxia-Induced Gene Expression Occurs Solely through the Action of Hypoxia-Inducible Factor 1α (HIF-1α): Role of Cytoplasmic Trapping of HIF-2α , 2003, Molecular and Cellular Biology.
[24] A. Harris,et al. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast , 1999, British Journal of Cancer.
[25] R. Dickson,et al. Growth factors in breast cancer. , 1995, Endocrine reviews.
[26] I. Taylor,et al. Endothelin-1: a multifunctional molecule in cancer , 2003, British Journal of Cancer.
[27] A. Harris,et al. Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. , 2003, Cancer research.
[28] P. Allavena,et al. Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2004, Novartis Foundation symposium.
[29] C. Lewis,et al. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. , 2004, Blood.
[30] J. Pollard. Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.
[31] Kouji Matsushima,et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract , 1998, Nature.
[32] F. Balkwill,et al. Hypoxia down‐regulates MCP‐1 expression: implications for macrophage distribution in tumors , 1998, Journal of leukocyte biology.
[33] T. Shono,et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis , 1997, Molecular and cellular biology.
[34] C. Lewis,et al. Expression of HIF‐1α by human macrophages: implications for the use of macrophages in hypoxia‐regulated cancer gene therapy , 2002, The Journal of pathology.
[35] Janice M. Y. Brown,et al. The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture. , 1999, Cancer research.
[36] A. Harris,et al. Expression of vascular endothelial growth factor by macrophages is up‐regulated in poorly vascularized areas of breast carcinomas , 2000, The Journal of pathology.
[37] F. Balkwill. The significance of cancer cell expression of the chemokine receptor CXCR4. , 2004, Seminars in cancer biology.
[38] A. Hollander,et al. Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. , 2001, Arthritis and rheumatism.
[39] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[40] A. Zampetaki,et al. Hypoxia induces macrophage inflammatory protein‐2 (MIP‐2) gene expression in murine macrophages via NF‐κB: the prominent role of p42/ p44 and PI3 kinase pathways , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] G. Hunninghake,et al. Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages. , 1996, American journal of respiratory cell and molecular biology.
[42] E. Guida,et al. Influence of Hypoxia and Glucose Deprivation on Tumour Necrosis Factor-Alpha and Granulocyte- Macrophage Colony-Stimulating Factor Expression in Human Cultured Monocytes , 1998, Cellular Physiology and Biochemistry.
[43] Cord Sunderkötter,et al. Macrophages and angiogenesis , 1994, Journal of leukocyte biology.
[44] Brian Keith,et al. Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation , 2003, Molecular and Cellular Biology.
[45] E. Crivellato,et al. The role of mast cells in tumour angiogenesis , 2001, British journal of haematology.
[46] K. Matsumoto,et al. Effects of hypoxia on cholesterol metabolism in human monocyte-derived macrophages. , 2000, Life sciences.
[47] Andrew V. Nguyen,et al. The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression , 2002, Journal of Mammary Gland Biology and Neoplasia.
[48] Lei Yao,et al. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. , 2002, Blood.
[49] M. Rudek,et al. Matrix Metalloproteinase Inhibitors: Do They Have a Place in Anticancer Therapy? , 2002, Pharmacotherapy.
[50] R. Bucala,et al. Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). , 2000, Seminars in cancer biology.
[51] Wood,et al. Matrix metalloproteinases and processing of pro‐TNF‐α , 1995, Journal of leukocyte biology.
[52] T. Tanimoto,et al. Cloning and expression of interleukin‐18 binding protein , 1999, FEBS letters.
[53] M. Matsumoto,et al. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[54] C. Lewis,et al. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. , 2003, The American journal of pathology.
[55] Marian Taylor,et al. Relation of Hypoxia-inducible Factor-2α (HIF-2α) Expression in Tumor-infiltrative Macrophages to Tumor Angiogenesis and the Oxidative Thymidine Phosphorylase Pathway in Human Breast Cancer , 2002 .
[56] M. Peppelenbosch,et al. Tissue factor signal transduction in angiogenesis. , 2003, Carcinogenesis.
[57] H. Redmond,et al. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor β-1 , 1998, Annals of Surgical Oncology.
[58] M. Pepper. Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[59] T. Gatanaga,et al. Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. , 1993, The Journal of surgical research.
[60] H. Shepard,et al. Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[61] A. Sica,et al. Tumor-associated macrophages: a molecular perspective. , 2002, International immunopharmacology.
[62] L. Matrisian,et al. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. , 1996, The international journal of biochemistry & cell biology.
[63] S. Ali,et al. Leucocyte chemotaxis: Examination of mitogen‐activated protein kinase and phosphoinositide 3‐kinase activation by Monocyte Chemoattractant Proteins‐1, ‐2, ‐3 and ‐4 , 2002, Clinical and experimental immunology.
[64] A. Harris,et al. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer , 2000, The Journal of pathology.
[65] C. Mundy,et al. Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis. , 2004, Genomics.
[66] Till Acker,et al. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice , 2002, Nature Medicine.
[67] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[68] Noam Brown,et al. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors , 2001, Journal of leukocyte biology.
[69] P. Carmeliet,et al. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice , 2002, Nature Medicine.
[70] J. McGee,et al. Macrophages in human breast disease: a quantitative immunohistochemical study. , 1988, British Journal of Cancer.
[71] Noam Brown,et al. The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.
[72] R. Strieter,et al. Chemokines: angiogenesis and metastases in lung cancer. , 2004, Novartis Foundation symposium.
[73] S. Saccani,et al. Regulation of the Chemokine Receptor CXCR4 by Hypoxia , 2003, The Journal of experimental medicine.
[74] S. Rafii,et al. Interleukin‐1α (IL‐1α) promotes angiogenesis in vivo via VEGFR‐2 pathway by inducing inflammatory cell VEGF synthesis and secretion , 2002 .
[75] T. Kita,et al. Differential Signaling for MCP‐1‐Dependent Integrin Activation and Chemotaxis , 2001, Annals of the New York Academy of Sciences.
[76] S. Pastorino,et al. Engineering of Macrophages to Produce IFN-γ in Response to Hypoxia1 , 2001, The Journal of Immunology.
[77] J. Schaper,et al. Regulation of EMAP II by hypoxia. , 2003, The American journal of pathology.
[78] F. Balkwill,et al. Endothelin‐2 is a macrophage chemoattractant: implications for macrophage distribution in tumors , 2002, European journal of immunology.
[79] Adrian L. Harris,et al. Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.
[80] P Vaupel,et al. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. , 2001, Seminars in oncology.
[81] R. Rees,et al. Chemokines induce migrational responses in human breast carcinoma cell lines , 1997, International journal of cancer.
[82] J. Pouysségur,et al. HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. , 2004, Biochemical pharmacology.
[83] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[84] L. Varesio,et al. Hypoxia inhibits the expression of the CCR5 chemokine receptor in macrophages. , 2004, Cellular immunology.
[85] I. Takanami,et al. Tumor-Associated Macrophage Infiltration in Pulmonary Adenocarcinoma: Association with Angiogenesis and Poor Prognosis , 1999, Oncology.
[86] Hong Sun,et al. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo , 1993, Cell.
[87] G. Arteel,et al. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. , 1999, Radiation research.
[88] L. Akslen,et al. Significance of tumour‐associated macrophages, vascular endothelial growth factor and thrombospondin‐1 expression for tumour angiogenesis and prognosis in endometrial carcinomas , 1999, International journal of cancer.
[89] J. Hibbs,et al. Nitric oxide: a cytotoxic activated macrophage effector molecule. , 1988, Biochemical and biophysical research communications.
[90] D. Connolly,et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration , 1990, The Journal of experimental medicine.
[91] J. D. De Larco,et al. The Potential Role of Neutrophils in Promoting the Metastatic Phenotype of Tumors Releasing Interleukin-8 , 2004, Clinical Cancer Research.
[92] P. Allavena,et al. Defective Expression of the Monocyte Chemotactic Protein-1 Receptor CCR2 in Macrophages Associated with Human Ovarian Carcinoma1 , 2000, The Journal of Immunology.
[93] Madeleine Moussa,et al. Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[94] A. Harris,et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.
[95] S. Pastorino,et al. Hypoxia Selectively Inhibits Monocyte Chemoattractant Protein-1 Production by Macrophages1 , 2004, The Journal of Immunology.
[96] David S. McClintock,et al. Role of Oxidants in NF-κB Activation and TNF-α Gene Transcription Induced by Hypoxia and Endotoxin1 , 2000, The Journal of Immunology.
[97] R. Strieter,et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.
[98] C. Koch,et al. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]. , 1995, British Journal of Cancer.